Abstract

Neuromuscular blocking agents (NMBAs) are a class of drugs used to produce skeletal muscle relaxation and paralysis most commonly to facilitate surgical and diagnostic procedure in anesthetized animals. A clear understanding of the physiologic events occurring at the neuromuscular junction is essential, as it is the site of action for drugs used to prevent muscular contraction. NMBAs can be broadly classified into two categories based on their mechanism of action: depolarizing NMBAs and nondepolarizing NMBAs. Currently, the most commonly used nondepolarizing NMBAs are atracurium, cis-atracurium, vecuronium, and rocuronium. They can be divided into two categories based on their chemical structure, benzylisoquinolines and aminosteroids. NMBAs are a unique class of drugs that are helpful in providing profound muscle relaxation and immobilization of patients during anesthesia. Use of NMBAs requires an ability to provide mechanical ventilation and monitoring of neuromuscular function.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.